AWS Healthcare global

Ultima Genomics

Ultima Genomics needed large-scale, cost-efficient compute for a sequencing platform whose basecalling and analysis pipeline depends on computer vision, deep learning, and repeated parallel experimentation to drive lower-cost genomics.

$100 genome
10 times more sequencing
100s of TBs of data processed and stored
10–20 hours

Reported impact

Business outcome

Ultima launched a sequencing platform targeting the $100 genome, uses AWS to process and store hundreds of terabytes of data, supports genomic use cases such as liquid biopsies, and can run parallel experiments that improve scale, cost, and accuracy.

  • Cost Reduction
  • Scalability
  • Speed to Market

Solution

Ultima Genomics uses AWS to accelerate the computational side of high-throughput DNA sequencing and pursue its goal of the $100 genome. Its UG 100 platform depends on a basecalling pipeline that processes camera-generated signals, applies computer-vision and deep-learning algorithms, and then performs downstream alignment and sorting to derive nucleotide sequences. Amazon EC2 G5 instances provide GPU-backed environments so scientists can spin up multiple experiments in parallel, while Amazon S3 and AWS HealthOmics help store and manage the large genomic datasets and workflows involved. This cloud-based setup lets researchers test algorithm changes without waiting for scarce fixed infrastructure, scale to hundreds of terabytes of processing and storage, and support advanced applications such as liquid biopsies and more diverse genomic databases.

Data flow

Raw signals from Ultima's sequencing cameras are processed through GPU-backed basecalling and deep-learning workflows on Amazon EC2, resulting genomic data is stored on Amazon S3, and larger omics workflows are managed with AWS HealthOmics.

Solution architecture

3 components · 3 layers
  1. Compute
    • Amazon EC2 G5 Instances Provide GPU-backed compute for basecalling experiments and genomics algorithm development.
  2. Storage
    • Amazon S3 Stores the large genomic datasets processed by Ultima's platform.
  3. Orchestration
    • AWS HealthOmics Supports genomics workflow and data management at scale.

Architecture clues

  • Basecalling pipeline chains computer vision, deep learning, alignment, and sorting.
  • Platform is designed for large genomics use cases such as liquid biopsies.
  • Scientists can launch multiple GPU experiments in parallel on demand.

Evidence from the source

Several customers are using the machine to develop advanced diagnostic tests called liquid biopsies.
The pipeline processes signals from a camera tool, applies computer vision and deep learning algorithms, and then uses further algorithms for alignment and sorting.
Ultima can spin up multiple test instances on Amazon EC2 to run experiments in parallel.
its technology provides unique advantages for liquid biopsies and also costs three to four times less than other solutions.
the UG 100, based on a new ultra-high-throughput sequencing architecture that reduces the cost per genome to $100.
Transparency Evidence & methodology 100/100 reference value · 90% confidence · 2 sources

Review how this reference was scored and trace each normalized claim back to its documented source.

01

Scoring methodology

How scores are calculated

Customer Reference Value measures usefulness as a customer reference. Evidence Confidence measures the quality and traceability of available evidence, not independent verification.

Customer reference value100/100
  • Problem clarity20/20
    Measures whether the customer's operational problem is specific enough to compare.
  • Implementation depth25/25
    Rewards named components, data flow, integrations, and architecture detail.
  • Outcome specificity20/20
    Measures whether the reported benefit is concrete rather than a generic claim.
  • Quantified impact25/25
    2 metrics describe measurable impact.
  • Deployment scale10/10
    Rewards evidence of a live or scaled deployment and meaningful integration scope.
Evidence confidence90%
  • Source authority20/25
    The main evidence is an official vendor-published customer story.
  • Claim traceability23/25
    11 of 12 key fields link to a named source.
  • Direct evidence20/20
    5 direct source quotes retained.
  • Date provenance8/10
    The publication date comes from publisher-controlled metadata.
  • Source transparency9/10
    2 source references document publisher, URL, authority, retrieval, and supported fields.
  • Implementation specificity10/10
    Rewards source-backed components, data flow, quantified impact, and a specific outcome.
02

Traceability

Sources & provenance

Field coverage shows which facts each source supports. Dates are shown only when documented by the source.

  1. AWS

    Ultima Genomics customer story

    First-party
    https://aws.amazon.com/solutions/case-studies/ultima-case-study/
    Source type
    Vendor-published customer story
    Published
    Jan 1, 2024
    Supports
    • Customer
    • Business problem
    • Solution
    • Products
    • Solution components
    • Data flow
    • Integrations
    • technical area
    • use case category
    • Business outcome
    • outcome category
    • Metrics
    • Architecture
    • evidence quotes
    • Publication date
  2. Built In

    Ultima Genomics Careers, Perks + Culture | Built In

    Third-party structured profile
    https://builtin.com/company/ultima-genomics

    The page's Organization schema lists numberOfEmployees value 303.

    Source type
    Structured company profile
    Supports
    • Company size

Date evidence

Not separately sourced Industry, Region. Treat these normalized attributes as lower-confidence until a dedicated source is added.